Roughly 95% of rare diseases lack a treatment or cure. While that is a stark fact that most of the 60 million patients with rare diseases in the US and EU face every day, society writ large also pays a dear price.
An analysis by Chiesi Farmaceutici S.p.A. estimated that the combined cost of rare diseases is ten times higher...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?